Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of metabolic disorders. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally https://graysonkhew429854.blog-mall.com/39678489/trelaglutide-exploring-a-new-option-for-chronic-diseases